T therapies is an expensive business. The fundamental problem is that CAR-T production is not a good fit for centralized manufacturing.

Key Points The transition from Waterfall to Scrum should take place gradually, using planned phases to implement the ...

CDR-Life today announced the appointment of Pascal Touchon, DVM, MBA, to its Board of Directors. Dr. Touchon brings 40 years of international experience in the biopharmaceutical industry, with ...

Coave Therapeutics (‘Coave’), a company pioneering the future of genetic medicines, today announces the evolution of its Scientific Advisory Board (SAB). This renewed SAB reflects Coave’s strategic ...

The new board will work with Abzena's scientific and commercial leadership to provide strategic guidance and insights.

Cell and gene therapies offer potential new therapeutics but are currently constrained by complex and inefficient manufacturing strategies.

The Disease Vector Education Center in St. Augustine, Florida, teaches kids about mosquitoes and disease prevention through ...

WatchGuard Technologies: The security supplier has announced a planned leadership change, revealing that CEO Prakash Panjwani will transition out of his operational role, continuing to serve on the ...

CPU Chip on Motherboard. AI Artificial Intelligence chipset on circuit board in futuristic concept suitable for future technology artwork, Web Banner Abstract background, Vector illustration AI ...